Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

2.55
-0.6800-21.05%
Post-market: 2.41-0.1400-5.49%19:59 EDT
Volume:744.25K
Turnover:2.12M
Market Cap:1.80M
PE:-0.02
High:3.06
Open:3.06
Low:2.26
Close:3.23
52wk High:212.10
52wk Low:2.26
Shares:705.25K
Float Shares:701.36K
Volume Ratio:15.80
T/O Rate:106.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.03
PE(LYR):-0.01

Loading ...

GlucoTrack Achieves Key Compliance Milestone and Advances Strategic Transformation

THOMSON REUTERS
·
Aug 17

GlucoTrack FY26 Q2 Net Loss Narrows 19.8% to USD 3.81 Million

Reuters
·
Aug 15

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 11

GlucoTrack - Enters Amendment No. 1 to Stock Purchase Agreement with White Lion Capital on Aug 7TH - SEC Filing

THOMSON REUTERS
·
Aug 11

GlucoTrack to Issue 2,505,513 Unregistered Shares to White Lion Capital Under Stock Purchase Agreement Amendment

Reuters
·
Aug 11

GlucoTrack Prices $2 Million Registered Direct Offering at $0.75 Per Unit

Reuters
·
Aug 05

GlucoTrack Announces $5.5 Million Financing

THOMSON REUTERS
·
Aug 05

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 01

GlucoTrack announces expansion of ai Futures Lab

TIPRANKS
·
Jul 31

GlucoTrack Unit Lokahi Therapeutics Expands Ai2 Futures Lab to 12 University Partnerships

Reuters
·
Jul 31

NASDAQ Trade Halt Volatility Trading Pause at 03:18 Pm

Reuters
·
Jul 31

Top Premarket Gainers

MT Newswires Live
·
Jul 30

GlucoTrack Unit Lokahi Therapeutics Targets Single-shot Lt-100 Dosing in Planned Q4 2026 Trial

Reuters
·
Jul 30

GlucoTrack Amends 8-K to Update Terms of $900,000 Note-for-shares Exchange Agreement

Reuters
·
Jul 30

Lokahi Therapeutics: Anticipates Clinical Evaluation of Single-Injection Lt-100 as Early as Q4 2026

THOMSON REUTERS
·
Jul 30

LŌKahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration

THOMSON REUTERS
·
Jul 30

GlucoTrack Enters Exchange Deal on $900,000 Promissory Note with Investor

Reuters
·
Jul 28

E.f. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

THOMSON REUTERS
·
Jul 18

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.f. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

THOMSON REUTERS
·
Jul 17

GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On

Benzinga
·
Jul 17